Actively Recruiting
Comparing Tegoprazan and Lansoprazole for Healing Bleeding Peptic Ulcers A Two-Week Double-Blind Randomized Study in Adults
Led by Mario Steffanus · Updated on 2025-05-29
162
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare the effects of two drugs, tegoprazan and lansoprazole, on healing bleeding peptic ulcers in adults. The study focuses on how effective these treatments are in promoting ulcer healing over a two-week period and evaluates their safety in the Indonesian population. Peptic ulcer disease involves damage to the stomach or duodenal lining, often caused by factors such as infection, medication use, or lifestyle habits. Newer drugs like tegoprazan may offer improved acid suppression compared to traditional treatments like lansoprazole. Participants in this trial will be randomly assigned to receive either tegoprazan 50 mg or lansoprazole 30 mg once daily for two weeks. Both treatments are taken orally, and the study is designed as a double-blind randomized trial to compare their healing effects. Endoscopic examinations will be done before starting treatment and after completion to assess ulcer healing. Researchers will also record any side effects experienced by participants during the study. During the trial, participants will undergo endoscopic assessments at the start and end of treatment to measure healing rates. They will be monitored for adverse effects throughout the two-week treatment period. The main outcome measured is the healing rate of the bleeding peptic ulcers after two weeks of treatment. The study will provide important information about how these drugs work in this patient group and help guide future treatment choices.
CONDITIONS
Brief Title
Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
Research Team
M
Mario Steffanus MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here